MedTrace Logo

Efficacy and Safety of Zolmitriptan by Sublingual Administration

NCT03377257 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2017-12-19

No results posted yet for this study

Summary

The purpose is to evaluate the effectiveness and safety profile of zolmitriptan by Sublingual administration for the acute treatment of Cluster headache.

Conditions

  • Cluster Headache

Interventions

DRUG

zolmitriptan by sublingual administration

Experimental group

DRUG

zolmitriptan by oral

Active group

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Li Li, MD · Xijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-31
Completion
2019-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377257 on ClinicalTrials.gov